SV2010003752A - Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas - Google Patents
Derivados de urea heterociclicos para el tratamiento de infecciones bacterianasInfo
- Publication number
- SV2010003752A SV2010003752A SV2010003752A SV2010003752A SV2010003752A SV 2010003752 A SV2010003752 A SV 2010003752A SV 2010003752 A SV2010003752 A SV 2010003752A SV 2010003752 A SV2010003752 A SV 2010003752A SV 2010003752 A SV2010003752 A SV 2010003752A
- Authority
- SV
- El Salvador
- Prior art keywords
- treatment
- bacterial infections
- urea
- heterociclic
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE DESCRIBEN COMPUESTOS DE FÓRMULA (I) Y SUS SALES FARMACÉUTICAMENTE ACEPTABLES. TAMBIÉN SE DESCRIBEN PROCEDIMIENTOS PARA SU PREPARACIÓN, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN, SU USO COMO MEDICAMENTOS Y SU USO EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS: (VER FORMULA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5873608P | 2008-06-04 | 2008-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2010003752A true SV2010003752A (es) | 2011-04-14 |
Family
ID=40823415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2010003752A SV2010003752A (es) | 2008-06-04 | 2010-12-06 | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas |
Country Status (23)
Country | Link |
---|---|
US (1) | US8283361B2 (es) |
EP (1) | EP2300463A1 (es) |
JP (1) | JP2011522026A (es) |
KR (1) | KR20110014710A (es) |
CN (1) | CN102105469A (es) |
AR (1) | AR072045A1 (es) |
AU (1) | AU2009254930A1 (es) |
BR (1) | BRPI0915471A2 (es) |
CA (1) | CA2725568A1 (es) |
CL (1) | CL2009001349A1 (es) |
CO (1) | CO6382176A2 (es) |
CR (1) | CR11825A (es) |
DO (1) | DOP2010000373A (es) |
EA (1) | EA201001858A1 (es) |
EC (1) | ECSP10010664A (es) |
IL (1) | IL209503A0 (es) |
MX (1) | MX2010013310A (es) |
PE (1) | PE20100155A1 (es) |
SV (1) | SV2010003752A (es) |
TW (1) | TW201000475A (es) |
UY (1) | UY31864A (es) |
WO (1) | WO2009147433A1 (es) |
ZA (1) | ZA201008610B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2006088246A1 (ja) * | 2005-02-18 | 2008-07-10 | 武田薬品工業株式会社 | Gpr34受容体機能調節剤 |
TW201102065A (en) * | 2009-05-29 | 2011-01-16 | Astrazeneca Ab | Heterocyclic urea derivatives and methods of use thereof |
UY32694A (es) * | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Derivados heterocíclicos de urea y métodos de uso de los mismos |
KR20130012072A (ko) | 2010-03-31 | 2013-01-31 | 액테리온 파마슈티칼 리미티드 | 항박테리아성 이소퀴놀린-3-일우레아 유도체 |
AR088729A1 (es) | 2011-03-29 | 2014-07-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica |
CN105067814A (zh) * | 2015-07-24 | 2015-11-18 | 中国科学院成都生物研究所 | 解旋酶水解atp活性测定方法 |
US11857352B2 (en) | 2016-09-06 | 2024-01-02 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
WO2018074880A2 (ko) * | 2016-10-20 | 2018-04-26 | 한국화학연구원 | 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물 |
RU2019133662A (ru) | 2017-03-24 | 2021-04-26 | Тайсо Фармасьютикал Ко., Лтд. | Производное 2(1h)-хинолинона |
CN111808089B (zh) * | 2019-04-10 | 2023-04-11 | 四川大学华西医院 | 一种治疗糖尿病的药物依格列净或其衍生物的制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0519449A1 (en) | 1991-06-21 | 1992-12-23 | Boehringer Mannheim Italia S.P.A. | 2-Amino-4-aryl thiazoles with antiasthmatic and antiinflammatory activities on the respiratory tract |
SI1341769T1 (sl) | 2000-12-15 | 2008-02-29 | Vertex Pharma | Inhibitorji bakterijske giraze in njihove uporabe |
AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
EP1861393A2 (en) * | 2005-03-04 | 2007-12-05 | AstraZeneca AB | Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
US8022816B2 (en) | 2005-03-21 | 2011-09-20 | Vela Systems, Inc. | System and method for field management using radio frequency tags |
US7569907B2 (en) | 2005-03-28 | 2009-08-04 | Cooper Technologies Company | Hybrid chip fuse assembly having wire leads and fabrication method therefor |
CN101156207A (zh) | 2005-04-13 | 2008-04-02 | 皇家飞利浦电子股份有限公司 | 在相位调制之前用水印进行编码 |
WO2007071965A2 (en) * | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines |
DE102006012337B3 (de) | 2006-03-17 | 2007-11-29 | Amphenol-Tuchel Electronics Gmbh | Elektrischer Steckverbinder |
BRPI0720057A2 (pt) * | 2006-12-04 | 2013-12-17 | Astrazeneca Ab | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de inibição de girase bacteriana de dna e/ou topoisomerase iv bacteriana em um animal de sangue quente, de produção de um efeito antibacteriano em um animal de sangue quente e de tratamento de uma infecção bacteriana em um animal de sangue quente, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo |
CN201038186Y (zh) | 2007-03-08 | 2008-03-19 | 鹤山丽得电子实业有限公司 | 一种大功率led |
TW200940537A (en) * | 2008-02-26 | 2009-10-01 | Astrazeneca Ab | Heterocyclic urea derivatives and methods of use thereof |
WO2009110688A2 (ko) | 2008-03-06 | 2009-09-11 | Jang Gum Sik | 태양광 발전 장치 |
UY32694A (es) * | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Derivados heterocíclicos de urea y métodos de uso de los mismos |
-
2009
- 2009-06-03 CL CL2009001349A patent/CL2009001349A1/es unknown
- 2009-06-03 UY UY0001031864A patent/UY31864A/es not_active Application Discontinuation
- 2009-06-03 CN CN2009801294194A patent/CN102105469A/zh active Pending
- 2009-06-03 EP EP09757805A patent/EP2300463A1/en not_active Withdrawn
- 2009-06-03 TW TW098118462A patent/TW201000475A/zh unknown
- 2009-06-03 EA EA201001858A patent/EA201001858A1/ru unknown
- 2009-06-03 AU AU2009254930A patent/AU2009254930A1/en not_active Abandoned
- 2009-06-03 BR BRPI0915471A patent/BRPI0915471A2/pt not_active IP Right Cessation
- 2009-06-03 KR KR1020117000030A patent/KR20110014710A/ko not_active Application Discontinuation
- 2009-06-03 MX MX2010013310A patent/MX2010013310A/es not_active Application Discontinuation
- 2009-06-03 US US12/477,781 patent/US8283361B2/en not_active Expired - Fee Related
- 2009-06-03 JP JP2011512216A patent/JP2011522026A/ja active Pending
- 2009-06-03 CA CA2725568A patent/CA2725568A1/en not_active Abandoned
- 2009-06-03 WO PCT/GB2009/050611 patent/WO2009147433A1/en active Application Filing
- 2009-06-04 AR ARP090102012A patent/AR072045A1/es unknown
- 2009-06-04 PE PE2009000774A patent/PE20100155A1/es not_active Application Discontinuation
-
2010
- 2010-11-22 IL IL209503A patent/IL209503A0/en unknown
- 2010-11-30 ZA ZA2010/08610A patent/ZA201008610B/en unknown
- 2010-12-03 DO DO2010000373A patent/DOP2010000373A/es unknown
- 2010-12-06 CR CR11825A patent/CR11825A/es not_active Application Discontinuation
- 2010-12-06 SV SV2010003752A patent/SV2010003752A/es not_active Application Discontinuation
- 2010-12-07 EC EC2010010664A patent/ECSP10010664A/es unknown
- 2010-12-22 CO CO10160874A patent/CO6382176A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2011522026A (ja) | 2011-07-28 |
ECSP10010664A (es) | 2011-01-31 |
IL209503A0 (en) | 2011-01-31 |
KR20110014710A (ko) | 2011-02-11 |
CL2009001349A1 (es) | 2010-12-31 |
US20100190745A1 (en) | 2010-07-29 |
CR11825A (es) | 2011-02-04 |
AR072045A1 (es) | 2010-08-04 |
BRPI0915471A2 (pt) | 2017-06-27 |
CA2725568A1 (en) | 2009-12-10 |
US8283361B2 (en) | 2012-10-09 |
CO6382176A2 (es) | 2012-02-15 |
MX2010013310A (es) | 2011-03-01 |
CN102105469A (zh) | 2011-06-22 |
TW201000475A (en) | 2010-01-01 |
DOP2010000373A (es) | 2011-01-15 |
AU2009254930A1 (en) | 2009-12-10 |
UY31864A (es) | 2010-01-29 |
EP2300463A1 (en) | 2011-03-30 |
PE20100155A1 (es) | 2010-03-25 |
WO2009147433A1 (en) | 2009-12-10 |
ZA201008610B (en) | 2012-08-29 |
EA201001858A1 (ru) | 2011-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11641A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
ECSP099451A (es) | Compuestos de urea policíclicos antibacterianos | |
SV2010003752A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
UY31860A (es) | Piridinas de tiazolo como inhibidoras de la adn girasa | |
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
UY31865A (es) | Derivados de urea heterocíclicos y métodos para la utilización de los mismos | |
UY31141A1 (es) | Compuestos de piperidina y sus usos | |
UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
CL2011000589A1 (es) | Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer. | |
DOP2011000203A (es) | Derivados de pirimidin indol para el tratamiento de cancer | |
SV2010003451A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
CO6640270A2 (es) | Morfolinopirimidad y su uso en terapia | |
ECSP109856A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842 | |
UY32856A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
ECSP099750A (es) | Imidazoquinolinas con propiedades inmunomoduladoras | |
UY31918A (es) | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
DOP2014000036A (es) | Compuestos de piridazinona y su uso como inhibidores daao | |
UY32694A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas | |
UY31839A (es) | Compuestos | |
UY32247A (es) | Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Lapse |